References
- Bullock MD, Pickard KM, Nielsen BS, et al (2013). Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis, 4, e684. https://doi.org/10.1038/cddis.2013.213
- Fendler A, Jung K (2013). MicroRNAs as new diagnostic and prognostic biomarkers in urological tumors. Crit Rev Oncog, 18, 289-302. https://doi.org/10.1615/CritRevOncog.2013007176
- Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet, 9, 102-14.
- Gargalionis AN, Basdra EK (2013). Insights in microRNAs Biology. Curr Top Med Chem, 13, 1493-502. https://doi.org/10.2174/15680266113139990098
- Kahlert C, Kalluri R (2013). Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl), 91, 431-7. https://doi.org/10.1007/s00109-013-1020-6
- Kong X, Du Y, Wang G, et al (2011). Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci, 56, 602-9. https://doi.org/10.1007/s10620-010-1285-3
- Lerner M, Lundgren J, Akhoondi S, et al (2011). MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle, 10, 2172-83. https://doi.org/10.4161/cc.10.13.16248
- Li Z, Hu S, Wang J, et al (2010). MiR-27a modulates MDR1/Pglycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol, 119, 125-30. https://doi.org/10.1016/j.ygyno.2010.06.004
- Li Y, Li W, Ouyang Q, et al (2011). Detection of lung cancer with blood microRNA-21 expression levels in Chinese population. Oncol Lett, 2, 991-4.
- Li M, Marin-Muller C, Bharadwaj U, et al (2009). MicroRNAs: control and loss of control in human physiology and disease. World J Surg, 33, 667-84. https://doi.org/10.1007/s00268-008-9836-x
- Liu D, Sun Q, Liang S, et al (2013). MicroRNA-27a inhibitors alone or in combination with perifosine suppress the growth of gastric cancer cells. Mol Med Rep, 7, 642-8.
- Liu T, Tang H, Lang Y, et al (2009). MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett, 273, 233-42. https://doi.org/10.1016/j.canlet.2008.08.003
- Lucas K, Raikhel AS (2013). Insect microRNAs: biogenesis, expression profiling and biological functions. Insect Biochem Mol Biol, 43, 24-38. https://doi.org/10.1016/j.ibmb.2012.10.009
- Mertens-Talcott SU, Chintharlapalli S, Li X, et al (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res, 67, 11001-11. https://doi.org/10.1158/0008-5472.CAN-07-2416
- Mohammed Abba, Heike Allgayer (2009). MicroRNAs as regulatory molecules in cancer: a focus on models defining miRNA functions. Drug Discov Today Dis Model, 6, 13-9. https://doi.org/10.1016/j.ddmod.2009.01.002
- Okayama H, Schetter AJ, Harris CC (2012). MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis, 30, 9-15. https://doi.org/10.1159/000341882
- Rothschild SI (2013). Epigenetic Therapy in Lung Cancer - Role of microRNAs. Front Oncol, 3, 158.
- Samimi H, Zaki Dizaji M, Ghadami M, et al (2013). MicroRNAs networks in thyroid cancers: focus on miRNAs related to the fascin. J Diabetes Metab Disord, 12, 31. https://doi.org/10.1186/2251-6581-12-31
- Schepeler T, Reinert JT, Ostenfeld MS, et al (2008). Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res, 68, 6416-24. https://doi.org/10.1158/0008-5472.CAN-07-6110
- Schultz NA, Andersen KK, Roslind A, et al (2012). Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index. World J Surg, 36, 2699-707. https://doi.org/10.1007/s00268-012-1705-y
- Wang X, Tang S, Le SY, et al (2008). Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One, 3, e2557. https://doi.org/10.1371/journal.pone.0002557
- Yan Z, Li J, Xiong Y, et al (2012). Identification of candidate colon cancer biomarkers by applying a random forest approach on microarray data. Oncol Rep, 28, 1036-42.
- Zhang J, Guo H, Qian G, et al (2010). Mir-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic networkr. Mol Cancer, 9, 211. https://doi.org/10.1186/1476-4598-9-211
- Zhang H, Li M, Han Y, et al (2010). Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci, 55, 2545-51. https://doi.org/10.1007/s10620-009-1051-6
- Zhao L, Bode AM, Cao Y, et al (2012). Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis, 33, 2220-7. https://doi.org/10.1093/carcin/bgs235
Cited by
- Optimization of Reference Genes for Normalization of the Quantitative Polymerase Chain Reaction in Tissue Samples of Gastric Cancer vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5815
- MiR-150-5p Suppresses Colorectal Cancer Cell Migration and Invasion through Targeting MUC4 vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6269
- MiR-454 Prompts Cell Proliferation of Human Colorectal Cancer Cells by Repressing CYLD Expression vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2397
- MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer vol.233, pp.2, 2017, https://doi.org/10.1002/jcp.25801